During 2014’s third quarter, device firms raised a total of $734 million, less than half of Q2’s $1.6 billion. (See Exhibit 1.) The deal activity was pretty evenly spread out among financing vehicles, with the exception of follow-on public offerings, which accounted for a mere 6% of the total with just one $6 million deal by biomaterials company Xtant Medical Holdings Inc.[See Deal]
Exhibi